ID UM-SCC-81A AC CVCL_7783 SY UMSCC-81A; UMSCC81A; University of Michigan-Squamous Cell Carcinoma-81A DR cancercelllines; CVCL_7783 DR GEO; GSM3631284 DR IARC_TP53; 21109 DR Progenetix; CVCL_7783 DR Wikidata; Q54990923 RX PubMed=9041179; RX PubMed=12884349; RX PubMed=15287027; RX PubMed=16785414; RX PubMed=17312569; RX PubMed=19760794; RX PubMed=28196595; RX PubMed=31090975; WW Info; MCLP; -; https://tcpaportal.org/mclp/ CC Part of: MD Anderson Cell Lines Project. CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=12884349). CC Omics: Genomics; Whole exome sequencing. CC Omics: Proteomics; Expression; Reverse-phase protein array. CC Omics: Transcriptomics; RNAseq. CC Omics: Variations; CNV analysis. CC Derived from site: In situ; Larynx; UBERON=UBERON_0001737. ST Source(s): PubMed=19760794 ST Amelogenin: X ST D13S317: 9 ST D18S51: 14,19 ST D21S11: 33.2 ST D3S1358: 15,17 ST D5S818: 11,12 ST D7S820: 9,11 ST D8S1179: 10 ST FGA: 22 ST vWA: 17 DI NCIt; C4044; Laryngeal squamous cell carcinoma DI ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx OX NCBI_TaxID=9606; ! Homo sapiens (Human) OI CVCL_7784 ! UM-SCC-81B SX Male AG 53Y CA Cancer cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 22 // RX PubMed=9041179; RA Frank C.J., McClatchey K.D., Devaney K.O., Carey T.E.; RT "Evidence that loss of chromosome 18q is associated with tumor RT progression."; RL Cancer Res. 57:824-827(1997). // RX PubMed=12884349; DOI=10.1002/hed.10274; RA Bradford C.R., Zhu S.-B., Ogawa H., Ogawa T., Ubell M., Narayan A., RA Johnson G., Wolf G.T., Fisher S.G., Carey T.E.; RT "p53 mutation correlates with cisplatin sensitivity in head and neck RT squamous cell carcinoma lines."; RL Head Neck 25:654-661(2003). // RX PubMed=15287027; DOI=10.1002/gcc.20066; RA Takebayashi S., Hickson A., Ogawa T., Jung K.-Y., Mineta H., Ueda Y., RA Grenman R., Fisher S.G., Carey T.E.; RT "Loss of chromosome arm 18q with tumor progression in head and neck RT squamous cancer."; RL Genes Chromosomes Cancer 41:145-154(2004). // RX PubMed=16785414; DOI=10.1001/archotol.132.6.668; RA Worsham M.J., Chen K.M., Meduri V., Nygren A.O.H., Errami A., RA Schouten J.P., Benninger M.S.; RT "Epigenetic events of disease progression in head and neck squamous RT cell carcinoma."; RL Arch. Otolaryngol. Head Neck Surg. 132:668-677(2006). // RX PubMed=17312569; DOI=10.1002/hed.20478; RA Lin C.J., Grandis J.R., Carey T.E., Gollin S.M., Whiteside T.L., RA Koch W.M., Ferris R.L., Lai S.Y.; RT "Head and neck squamous cell carcinoma cell lines: established models RT and rationale for selection."; RL Head Neck 29:163-188(2007). // RX PubMed=19760794; DOI=10.1002/hed.21198; PMCID=PMC3292176; RA Brenner J.C., Graham M.P., Kumar B., Saunders L.M., Kupfer R., RA Lyons R.H., Bradford C.R., Carey T.E.; RT "Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell RT lines."; RL Head Neck 32:417-426(2010). // RX PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005; PMCID=PMC5501076; RA Li J., Zhao W., Akbani R., Liu W.-B., Ju Z.-L., Ling S.-Y., Vellano C.P., RA Roebuck P., Yu Q.-H., Eterovic A.K., Byers L.A., Davies M.A., Deng W.-L., RA Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D., RA Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y.-L., Mills G.B., RA Liang H.; RT "Characterization of human cancer cell lines by reverse-phase protein RT arrays."; RL Cancer Cell 31:225-239(2017). // RX PubMed=31090975; DOI=10.1002/hed.25803; PMCID=PMC6692232; RA Mann J.E., Kulkarni A., Birkeland A.C., Kafelghazal J., Eisenberg J., RA Jewell B.M., Ludwig M.L., Spector M.E., Jiang H., Carey T.E., RA Brenner J.C.; RT "The molecular landscape of the University of Michigan laryngeal RT squamous cell carcinoma cell line panel."; RL Head Neck 41:3114-3124(2019). //